Literature DB >> 2164458

Low sodium intake corrects abnormality in beta-receptor-mediated arterial vasodilation in patients with hypertension: correlation with beta-receptor function in vitro.

T Naslund1, D J Silberstein, W J Merrell, J H Nadeau, A J Wood.   

Abstract

To determine the contribution of altered beta-receptor function in the vasculature to the increased peripheral vascular resistance seen in hypertension, the effects of intra-arterial infusions of isoproterenol and epinephrine on forearm blood flow were determined in 11 male normotensive subjects and 11 male hypertensive subjects during 10 and 250 mmol/day sodium diets. Increased sodium intake from 10 to 250 mmol produced contrasting effects in the hypertensive and normotensive subjects. In the hypertensive subjects, sensitivity to isoproterenol decreased when sodium intake increased (median effective dose increased from 39 [95% confidence limits, 30 to 50] to 70 [95% confidence limits, 42 to 116] ng/min, p less than 0.05). On the other hand, in the normotensive subjects increased sodium intake resulted in an increased sensitivity to isoproterenol induced vasodilation (median effective dose decreased from 52 [38 to 71] to 29 [22 to 38] ng/min, p less than 0.01). No change occurred in sensitivity to epinephrine or in the maximum vasodilatory response to ischemia during dietary changes. Changes in beta-receptors on lymphocyte membranes paralleled the changes seen in vascular sensitivity so that the proportion of receptors exhibiting high affinity for agonists, a reflection of receptor adenylate cyclase coupling, decreased in the hypertensive subjects from 38.0% +/- 3.8% when they were receiving 10 mmol/day sodium to 29.6% +/- 2.7% when they were receiving 250 mmol/day sodium (p less than 0.01). However, the proportion increased from 32.4% +/- 3.7% for normotensive subjects receiving 10 mmol/day sodium to 47.1% +/- 7.8% for normotensive subjects receiving 250 mmol/day sodium (p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2164458     DOI: 10.1038/clpt.1990.121

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  14 in total

1.  The Arg16Gly polymorphism of the beta2-adrenergic receptor and the natriuretic response to rapid saline infusion in humans.

Authors:  Eric M Snyder; Stephen T Turner; Michael J Joyner; John H Eisenach; Bruce D Johnson
Journal:  J Physiol       Date:  2006-05-25       Impact factor: 5.182

2.  Interactions between beta-2 adrenoceptor gene variation, cardiovascular control and dietary sodium in healthy young adults.

Authors:  John H Eisenach; Darrell R Schroeder; Emily S Pavey; Alan R Penheiter; Jean N Knutson; Stephen T Turner; Michael J Joyner
Journal:  J Physiol       Date:  2014-09-25       Impact factor: 5.182

3.  Effects of gender, age and hypertension on beta-adrenergic receptor function in rat urinary bladder.

Authors:  Elfaridah P Frazier; Tim Schneider; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-05-31       Impact factor: 3.000

4.  Matrix metalloproteinases cleave the beta2-adrenergic receptor in spontaneously hypertensive rats.

Authors:  Stephen F Rodrigues; Edward D Tran; Zuleica B Fortes; Geert W Schmid-Schönbein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-09       Impact factor: 4.733

5.  Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension.

Authors:  C M Stein; R Nelson; R Deegan; H He; M Wood; A J Wood
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

6.  G-protein-coupled receptor kinase activity is increased in hypertension.

Authors:  R Gros; J L Benovic; C M Tan; R D Feldman
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

7.  Dietary sodium restriction and beta2-adrenergic receptor polymorphism modulate cardiovascular function in humans.

Authors:  John H Eisenach; Darrell R Schroeder; Tasha L Pike; Christopher P Johnson; William G Schrage; Eric M Snyder; Bruce D Johnson; Vesna D Garovic; Stephen T Turner; Michael J Joyner
Journal:  J Physiol       Date:  2006-06-01       Impact factor: 5.182

8.  Beta2-adrenergic receptor genotype affects the renin-angiotensin-aldosterone system response to the Dietary Approaches to Stop Hypertension (DASH) dietary pattern.

Authors:  Bei Sun; Jonathan S Williams; Laura P Svetkey; Nikheel S Kolatkar; Paul R Conlin
Journal:  Am J Clin Nutr       Date:  2010-06-02       Impact factor: 7.045

9.  Insulin-mediated sensitization of adenylyl cyclase activation.

Authors:  R D Feldman
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

10.  Effect of inhibition of extracellular signal-regulated kinase on relaxations to beta-adrenoceptor agonists in porcine isolated blood vessels.

Authors:  C O Uhiara; S P H Alexander; R E Roberts
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.